Resmed Inc. buy UBS Group AG
Start price
24.04.25
/
50%
€207.50
Target price
24.04.26
€251.00
Performance (%)
-4.70%
Price
08.04.26
€197.75
Summary
This prediction is currently active. With a performance of -4.70%, the BUY prediction for Resmed Inc. by UBS_Group_AG is down slightly. This prediction currently runs until 24.04.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 2.781% | 2.781% |
| iShares Core DAX® | 3,01 % | 1,44 % |
| iShares Nasdaq 100 | 3,01 % | 0,57 % |
| iShares Nikkei 225® | 4,14 % | 4,55 % |
| iShares S&P 500 | 2,38 % | 0,24 % |
Comments by UBS_Group_AG for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target lowered by analysts at UBS Group AG from $290.00 to $285.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat